PHARMING ANNOUNCES RESEARCH COLLABORATION

Pharming Group ("Pharming" or "the Company") announced today a research collaboration with NovaThera ("NovaThera"). Pharming and NovaThera are to collaborate on combining NovaThera's proprietary biomaterial products with Pharming's recombinant proteins such as human collagen, fibrinogen, lactoferrin and C1 inhibitor. The collaboration takes advantage of the complementary capabilities of products from Pharming and Novathera and could provide Pharming with several new products.

PrimeZone Media Network (http://www.primezone.com/newsroom/news_releases.mhtml?d=81551)